-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Mental and behavioural disorders
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
- prev
- Page 6 of 2
17 results found filtered by Blood and immune system Remove Blood and immune system Filter Clear Search
-
NICE MTA Guidance No 246 – Pharmalgen for the treatment of bee and wasp venom allergy
- Published
- 22 February 2012
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 84 - The use of drotrecogin alfa (activated) for severe sepsis
- Published
- 25 October 2011
- Cycle of Improvement
- Evidence
-
Blood Transfusion Record
- Published
- 01 October 2010
- Cycle of Improvement
- Improvement
-
Evidence based assessment report 2010-003
- Published
- 29 July 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 164 – Febuxostat for the management of hyperuricaemia in people with gout
- Published
- 16 December 2009
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2009-003
- Published
- 18 August 2009
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2009-001
- Published
- 17 February 2009
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2008-003
- Published
- 05 November 2008
- Cycle of Improvement
- Evidence
-
Blood Transfusion National Overview
- Published
- 01 October 2008
- Cycle of Improvement
- Scrutiny
-
Blood Transfusion local reports
- Published
- 29 July 2008
- Cycle of Improvement
- Scrutiny